No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
Nodding syndrome has been suggested to be triggered by neurotoxic leiomodin-1 auto-antibodies cross-reacting with <i>Onchocerca volvulus</i>. Here, we screened serum and CSF samples of persons with nodding syndrome and other forms of onchocerciasis-associated epilepsy (OAE) and African a...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/7/845 |
id |
doaj-751fc968f91a465d81245d36caf75484 |
---|---|
record_format |
Article |
spelling |
doaj-751fc968f91a465d81245d36caf754842021-07-23T13:59:32ZengMDPI AGPathogens2076-08172021-07-011084584510.3390/pathogens10070845No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated EpilepsyAn Hotterbeekx0Melissa Krizia Vieri1Melanie Ramberger2Ashraf Jozefzoon-Aghai3Michel Mandro4Floribert Tepage5Alfred Dusabimana6Samir Kumar-Singh7Maarten J. Titulaer8Robert Colebunders9Global Health Institute, University of Antwerp, 2610 Antwerp, BelgiumGlobal Health Institute, University of Antwerp, 2610 Antwerp, BelgiumDepartment of Neurology, Erasmus MC University Medical Center, 3015 Rotterdam, The NetherlandsDepartment of Neurology, Erasmus MC University Medical Center, 3015 Rotterdam, The NetherlandsProvincial Health Division of Ituri, Ministry of Health, Bunia, Democratic Republic of the CongoMinistry of Health, Buta, Democratic Republic of the CongoGlobal Health Institute, University of Antwerp, 2610 Antwerp, BelgiumMolecular Pathology Group, Laboratory of Cell Biology and Histology, University of Antwerp, 2610 Antwerp, BelgiumDepartment of Neurology, Erasmus MC University Medical Center, 3015 Rotterdam, The NetherlandsGlobal Health Institute, University of Antwerp, 2610 Antwerp, BelgiumNodding syndrome has been suggested to be triggered by neurotoxic leiomodin-1 auto-antibodies cross-reacting with <i>Onchocerca volvulus</i>. Here, we screened serum and CSF samples of persons with nodding syndrome and other forms of onchocerciasis-associated epilepsy (OAE) and African and European controls for leiomodin-1 antibodies by a cell-based assay (CBA) and Western blot (WB). These samples were also investigated for the presence of auto-antibodies cross-reacting with rat brain tissue by immunohistochemistry (IHC). Additionally, IHC was used to detect the leiomodin-1 protein in post-mortem brain samples of persons with OAE who died. Leiomodin-1 antibodies were detected by CBA in 6/52 (12%) and by WB in 23/54 (43%) persons with OAE compared to in 14/61 (23%) (<i>p =</i> 0.113) and 23/54 (43%) <i>(p =</i> 0.479) of controls without epilepsy. Multivariable exact logistic regression did not show an association between <i>O. volvulus</i> infection or epilepsy status and the presence of leiomodin-1. Leiomodin-1 antibodies were not detected in 12 CSF samples from persons with OAE or in 16 CSF samples from persons with acute-onset neurological conditions, as well as not being detected in serum from European controls. Moreover, the leiomodin-1 protein was only detected in capillary walls in post-mortem brain tissues and not in brain cells. IHC on rat brain slides with serum samples from persons with OAE or controls from persons with or without <i>O. volvulus</i> infection revealed no specific staining pattern. In conclusion, our data do not support OAE to be an autoimmune disorder caused by leiomodin-1 antibodies.https://www.mdpi.com/2076-0817/10/7/845onchocerciasis-associated epilepsynodding syndromeleiomodin-1autoimmune |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
An Hotterbeekx Melissa Krizia Vieri Melanie Ramberger Ashraf Jozefzoon-Aghai Michel Mandro Floribert Tepage Alfred Dusabimana Samir Kumar-Singh Maarten J. Titulaer Robert Colebunders |
spellingShingle |
An Hotterbeekx Melissa Krizia Vieri Melanie Ramberger Ashraf Jozefzoon-Aghai Michel Mandro Floribert Tepage Alfred Dusabimana Samir Kumar-Singh Maarten J. Titulaer Robert Colebunders No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy Pathogens onchocerciasis-associated epilepsy nodding syndrome leiomodin-1 autoimmune |
author_facet |
An Hotterbeekx Melissa Krizia Vieri Melanie Ramberger Ashraf Jozefzoon-Aghai Michel Mandro Floribert Tepage Alfred Dusabimana Samir Kumar-Singh Maarten J. Titulaer Robert Colebunders |
author_sort |
An Hotterbeekx |
title |
No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy |
title_short |
No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy |
title_full |
No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy |
title_fullStr |
No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy |
title_full_unstemmed |
No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy |
title_sort |
no evidence for the involvement of leiomodin-1 antibodies in the pathogenesis of onchocerciasis-associated epilepsy |
publisher |
MDPI AG |
series |
Pathogens |
issn |
2076-0817 |
publishDate |
2021-07-01 |
description |
Nodding syndrome has been suggested to be triggered by neurotoxic leiomodin-1 auto-antibodies cross-reacting with <i>Onchocerca volvulus</i>. Here, we screened serum and CSF samples of persons with nodding syndrome and other forms of onchocerciasis-associated epilepsy (OAE) and African and European controls for leiomodin-1 antibodies by a cell-based assay (CBA) and Western blot (WB). These samples were also investigated for the presence of auto-antibodies cross-reacting with rat brain tissue by immunohistochemistry (IHC). Additionally, IHC was used to detect the leiomodin-1 protein in post-mortem brain samples of persons with OAE who died. Leiomodin-1 antibodies were detected by CBA in 6/52 (12%) and by WB in 23/54 (43%) persons with OAE compared to in 14/61 (23%) (<i>p =</i> 0.113) and 23/54 (43%) <i>(p =</i> 0.479) of controls without epilepsy. Multivariable exact logistic regression did not show an association between <i>O. volvulus</i> infection or epilepsy status and the presence of leiomodin-1. Leiomodin-1 antibodies were not detected in 12 CSF samples from persons with OAE or in 16 CSF samples from persons with acute-onset neurological conditions, as well as not being detected in serum from European controls. Moreover, the leiomodin-1 protein was only detected in capillary walls in post-mortem brain tissues and not in brain cells. IHC on rat brain slides with serum samples from persons with OAE or controls from persons with or without <i>O. volvulus</i> infection revealed no specific staining pattern. In conclusion, our data do not support OAE to be an autoimmune disorder caused by leiomodin-1 antibodies. |
topic |
onchocerciasis-associated epilepsy nodding syndrome leiomodin-1 autoimmune |
url |
https://www.mdpi.com/2076-0817/10/7/845 |
work_keys_str_mv |
AT anhotterbeekx noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy AT melissakriziavieri noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy AT melanieramberger noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy AT ashrafjozefzoonaghai noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy AT michelmandro noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy AT floriberttepage noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy AT alfreddusabimana noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy AT samirkumarsingh noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy AT maartenjtitulaer noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy AT robertcolebunders noevidencefortheinvolvementofleiomodin1antibodiesinthepathogenesisofonchocerciasisassociatedepilepsy |
_version_ |
1721286565185978368 |